Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
00874
Company Profile
Business description
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segments include Great Southern TCM; Great Health; Great Commerce and Great Medical Care. The company generates maximum revenue from the Great Commerce segment.
Contact
45 Sha Mian North Street
Liwan District
Guangdong Province
Guangzhou510130
CHNT: +86 2066281218
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
27,425
Stocks News & Analysis
stocks
Goldman Sachs Earnings: Valuations remain stretched
We raise our fair value estimate for Goldman Sachs stock.
stocks
Major ASX listed miners overvalued
We’ve adjusted our fair values after updating our commodity price assumptions.
stocks
Undervalued ASX share with pathway to positive cash flow
Higher sales and a new loan facility increase our conviction.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,181.00 | 26.30 | -0.29% |
| CAC 40 | 8,258.94 | 54.18 | -0.65% |
| DAX 40 | 25,297.13 | 55.26 | -0.22% |
| Dow JONES (US) | 49,359.33 | 83.11 | -0.17% |
| FTSE 100 | 10,235.29 | 3.65 | -0.04% |
| HKSE | 26,578.00 | 266.96 | -0.99% |
| NASDAQ | 23,515.39 | 14.63 | -0.06% |
| Nikkei 225 | 53,456.34 | 479.83 | -0.89% |
| NZX 50 Index | 13,582.22 | 135.88 | -0.99% |
| S&P 500 | 6,940.01 | 4.46 | -0.06% |
| S&P/ASX 200 | 8,861.20 | 22.50 | -0.25% |
| SSE Composite Index | 4,107.18 | 5.26 | 0.13% |